Global High-Throughput Sequencing NGS Market Growth (Status and Outlook) 2023-2029

Global High-Throughput Sequencing NGS Market Growth (Status and Outlook) 2023-2029

Next Generation Sequencing (NGS), also known as high-throughput sequencing or deep-sequencing (Deep-sequencing), can sequence and analyze hundreds of thousands to millions of DNA fragments at a time. In 2014, the journal Nature Methods selected NGS technology as the first of the top ten technologies that have had the greatest impact on biological research in the past decade.

LPI (LP Information)' newest research report, the “High-Throughput Sequencing NGS Industry Forecast” looks at past sales and reviews total world High-Throughput Sequencing NGS sales in 2022, providing a comprehensive analysis by region and market sector of projected High-Throughput Sequencing NGS sales for 2023 through 2029. With High-Throughput Sequencing NGS sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world High-Throughput Sequencing NGS industry.

This Insight Report provides a comprehensive analysis of the global High-Throughput Sequencing NGS landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on High-Throughput Sequencing NGS portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global High-Throughput Sequencing NGS market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for High-Throughput Sequencing NGS and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global High-Throughput Sequencing NGS.

The global High-Throughput Sequencing NGS market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for High-Throughput Sequencing NGS is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for High-Throughput Sequencing NGS is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for High-Throughput Sequencing NGS is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key High-Throughput Sequencing NGS players cover Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences and Macrogen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of High-Throughput Sequencing NGS market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing

Segmentation by application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link

Please note: The report will take approximately 2 business days to prepare and deliver.